39 related articles for article (PubMed ID: 9972639)
1. ATYPICAL NEUROLEPTIC MALIGNANT SYNDROME ASSOCIATED WITH MIRTAZAPINE USE.
Ağaç T; Gökçay H; Solmaz M
Psychiatr Danub; 2023; 35(4):587-590. PubMed ID: 37992105
[No Abstract] [Full Text] [Related]
2. Neuroleptic Malignant Syndrome Associated With Lurasidone: A Case Report.
Pàmpols-Pérez S; Gisbert-Solà A; Resa-Pérez B; Jiménez-Mayoral A; Forcada-Pach I; Llorca-Bofi V
J Clin Psychopharmacol; 2023 Nov-Dec 01; 43(6):548-549. PubMed ID: 37930214
[No Abstract] [Full Text] [Related]
3. Elevated Creatine Phosphokinase in a Patient on a Long-Acting Antipsychotic: A Challenging Presentation Similar to Neuroleptic Malignant Syndrome.
Ashraf S; Kochhar H; Jenson C; Griffin B; Shah K; Mansuri Z; Bachu A
Prim Care Companion CNS Disord; 2023 Sep; 25(5):. PubMed ID: 37748136
[No Abstract] [Full Text] [Related]
4. Neuroleptic Malignant Syndrome After Lithium Withdrawal.
Okubo S; Bannai T; Seki T; Shiio Y
J Clin Psychopharmacol; 2023 Sep-Oct 01; 43(5):464-466. PubMed ID: 37683240
[No Abstract] [Full Text] [Related]
5. Pharmacological Considerations of Neuroleptic Malignant Syndrome in a Patient on a Long-Acting Antipsychotic.
Mashiana A; Pierce M
J Acad Consult Liaison Psychiatry; 2023; 64(4):403-404. PubMed ID: 37474243
[No Abstract] [Full Text] [Related]
6. Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique.
Hasan S; Buckley P
Am J Psychiatry; 1998 Aug; 155(8):1113-6. PubMed ID: 9699705
[TBL] [Abstract][Full Text] [Related]
7. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
Liu PY; Wu PC; Chen CY; Chen YC
Gen Hosp Psychiatry; 2011; 33(1):84.e5-7. PubMed ID: 21353143
[TBL] [Abstract][Full Text] [Related]
8. Catatonia and mild neuroleptic malignant syndrome after initiation of long-acting injectable risperidone: case report.
Mall GD; Hake L; Benjamin AB; Adityanjee A
J Clin Psychopharmacol; 2008 Oct; 28(5):572-3. PubMed ID: 18794658
[No Abstract] [Full Text] [Related]
9. [Neuroleptic malignant syndrome in users of risperidone].
Kroon JG
Ned Tijdschr Geneeskd; 2005 Jan; 149(3):157-8; author reply 158. PubMed ID: 15693594
[No Abstract] [Full Text] [Related]
10. [Neuroleptic malignant syndrome in users of risperidone].
Bonte-Mineur F; Geerlings CJ; Rietveld AP
Ned Tijdschr Geneeskd; 2005 Jan; 149(3):158-9; author reply 159. PubMed ID: 15693595
[No Abstract] [Full Text] [Related]
11. [Neuroleptic malignant syndrome in users of risperidone].
van Bemmel T; Westendorp RG
Ned Tijdschr Geneeskd; 2005 Mar; 149(11):608; author reply 608. PubMed ID: 15799646
[No Abstract] [Full Text] [Related]
12. [The risperidone-associated neuroleptic malignant syndrome in a pediatric patient].
Villanueva Lamas J; García García J; Alda Diez JA; Tous Andreu N
An Esp Pediatr; 1998 Dec; 49(6):652-3. PubMed ID: 9972639
[No Abstract] [Full Text] [Related]
13. Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia.
Aboraya A; Schumacher J; Abdalla E; LePage J; McGhee M; Butcher D; Griffin H; Shahda M
W V Med J; 2002; 98(2):63-5. PubMed ID: 12048741
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
